Albany Molecular (AMRI) to Cease Operations in Budapest
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Join SI Premium – FREE
According to an 8-K just filed, Albany Molecular (Nasdaq: AMRI) will cease all operations in Budapest. The company said the move will affect about 100 workers. Albany said it is still estimating the costs of closing the Budapest operations.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Lazard Global Total Return fund declares $0.1534 monthly distribution
- BIGG Digital Assets to rename as Surge Digital, consolidate shares
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
